SCHEMBL4239001

SCHEMBL4239001

O=C(O)CC(N1C(=O)CCC1=O)(N1C(=O)CCC1=O)C(C(=O)OCC(CO)(CO)CO)(N1C(=O)CCC1=O)N1C(=O)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2524574 0.83
SCHEMBL2023512 0.78
SCHEMBL3485305 0.75 ALDH1A1 (0.32)
Water SCHEMBL6913374 0.74 ALDH1A1 (0.31)
Oxirane SCHEMBL1375156 0.70 SLC13A5 (0.31)
SCHEMBL3748421 0.66
SCHEMBL413416 0.65
SCHEMBL32675817 0.64 TSHR (0.32)
SCHEMBL2589615 0.62 ALDH1A1 (0.32)
SCHEMBL3719747 0.61 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090028957-A1 Implantable Tissue-Reactive Biomaterial Compositions and Systems, and Methods of Us Thereof DANILOFF GEORGE Y 2009-01-29 US disclosed
WO-2006113845-A1 IMPLANTABLE TISSUE-REACTIVE BIOMATERIAL COMPOSITIONS AND SYSTEMS, AND METHODS OF USE THEREOF THERABIT, INC. (US) 2006-10-26 WO disclosed